Kronisk rhinosinusitis med næsepolypper (CRSwNP)
Artikel
Kronisk rhinosinusitis med næsepolypper: Samspillet mellem type 2-inflammation og lugtesanstab
Loss of Smell in CRSwNP
Loss of sense of smell is a common symptom of chronic rhinosinusitis with nasal polyps (CRSwNP), but its impact is often underestimated. Learn how olfactory dysfunction affects patient’s quality of life and explore the underlying mechanisms driving smell loss in CRSwNP.
Real-World Evidence and Phase IV studies in CRSwNP
Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) generally have a high symptom burden and poor health-related quality of life (QoL), often requiring recurring systemic corticosteroid use and repeated sinus surgery.
DUPIREAL: Two-Year Turning Point with Dupilumab in CRSwNP
The results from the DUPIREAL real-world study reinforce the efficacy of dupilumab demonstrated in the SINUS-24 and SINUS-52 randomized clinical trials and are consistent with the approved SmPC.1,2,3,4 DUPIREAL is the largest long-term real-world study (n=926) evaluating the effectiveness of dupilumab, including treatment response, disease control and remission, in severe uncontrolled CRSwNP over 2 years.2,3
EVEREST study: First ever direct Head-to-Head Comparison of Biologics in Patients with Severe CRSwNP and Coexisting Asthma
First ever direct Head-to-Head Comparison of Biologics in Patients with Severe CRSwNP and Coexisting Asthma.
